SCHEMBL5152307

SCHEMBL5152307

CCCC(O)COC1C(C)CCCC1(C)C

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8528896 0.88 UGT2B7 (0.32) MEN1KMT2A
SCHEMBL10895015 0.84
SCHEMBL11201500 0.82
SCHEMBL10895685 0.78 UGT2B7 (0.32)
SCHEMBL5152981 0.78
SCHEMBL14620479 0.78
SCHEMBL14620296 0.78
SCHEMBL14620297 0.78
SCHEMBL12977887 0.74 UGT2B7 (0.30)
SCHEMBL24425869 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0081699-B1 ALICYCLIC COMPOUNDS, THEIR USE AS PERFUME OR FLAVOURING AGENTS AND PROCESS FOR THEIR PREPARATION FIRMENICH SA (CH) 1985-01-23 EP claimed
EP-0081699-A1 Alicyclic compounds, their use as perfume or flavouring agents and process for their preparation FIRMENICH SA (CH) 1983-06-22 EP claimed
EP-4706627-A2 LAUNDRY COMPOSITION Firmenich SA (CH) 2026-03-11 EP disclosed
EP-4077626-B1 LAUNDRY COMPOSITION FIRMENICH & CIE (CH) 2026-02-11 EP disclosed
US-20240058240-A1 COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING COMPOSITIONS THEREOF CHEMCOM S.A. (BE) 2024-02-22 US disclosed
EP-4171479-A1 USE OF COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING COMPOSITIONS THEREOF ChemCom S.A. (BE) 2023-05-03 EP disclosed
WO-2021260168-A1 USE OF COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING COMPOSITIONS THEREOF CHEMCOM S.A. (BE) 2021-12-30 WO disclosed
EP-1136061-B1 Optically active, oxygenated, alicyclic compounds and their use as perfuming ingredients FIRMENICH & CIE (CH) 2007-01-03 EP disclosed
US-20010031710-A1 Optically active, oxygenated, alicyclic compounds and their use as perfuming ingredients FIRMENICH SA (CH) 2001-10-18 US disclosed
EP-1136061-A2 Optically active, oxygenated, alicyclic compounds and their use as perfuming ingredients FIRMENICH SA (CH) 2001-09-26 EP disclosed
EP-0616994-B1 Process for producing ether alcohols by hydrogenolysis of cyclic ketal KAO CORP (JP) 1998-12-30 EP disclosed
US-5446208-A Process for producing ether alcohols by hydrogenolysis of cyclic ketal KAO CORPORATION (JP) 1995-08-29 US disclosed
EP-0616994-A2 Process for producing ether alcohols by hydrogenolysis of cyclic ketal KAO CORPORATION (JP) 1994-09-28 EP disclosed
US-4608445-A ORGANOLEPTIC FIRMENICH SA (CH) 1986-08-26 US disclosed
EP-0081699-B1 ALICYCLIC COMPOUNDS, THEIR USE AS PERFUME OR FLAVOURING AGENTS AND PROCESS FOR THEIR PREPARATION FIRMENICH SA (CH) 1985-01-23 EP disclosed
EP-0081699-A1 Alicyclic compounds, their use as perfume or flavouring agents and process for their preparation FIRMENICH SA (CH) 1983-06-22 EP disclosed
EP-0081699-A1 Alicyclic compounds, their use as perfume or flavouring agents and process for their preparation FIRMENICH SA (CH) 1983-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240058240-A1 COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING COMPOSITIONS THEREOF TYR, MC1R, MITF MEN1 178/4885KMT2A 2506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.